Replies to post #36187 on CV Sciences Inc (CVSI)

[jefra1965]

SAN DIEGO & LAS VEGAS--(BUSINESS WIRE)--Shareholder rights law firm Robbins Arroyo LLP announces that a purchaser of CV Sciences, Inc. (Other OTC: CVSI) has filed a shareholder derivative complaint against the company's officers and directors for alleged breaches of fiduciary duties from June 19, 2017 through the present. CV Sciences is a life science company that focuses on developing products using synthetic cannabidiol ("CBD"). The company's lead product is known as CVSI-007, a chewing gum containing nicotine and CBD designed to aid in the cessation of smokeless tobacco use.

https://www.businesswire.com/news/home/20181204006186/en/Robbins-Arroyo-LLP-CV-Sciences-CVSI-Misled

Any investor who bought stock of CVSI on Aug 20 2018 (Or any other previous date) @ $6.41 a piece thinking that the company's lead product is CVSI-007 is just plain ignorant. Period.

[jefra1965]

Seems like a Pre-Farm Bill continuation "SHORT Attack". But with the same old misleading arguments. Let's see how effective is it? Looks like a reload opportunity @ best.
Also great timing when the market is closed tomorrow. What a pest.

[SpaceLady]

I live in the San Diego area, and I think I will contact CV Sciences, and tell them I am willing to be a witness on their behalf as a shareholder who understood the patent process. Make that lawyer look stupid!

[ap17]

Add my name to the counterclaim. I have all the time in the world to make them pay.

At some point in their escapades they need to know that their nonsense can backfire and at a cost.